Ilias Frydas

Dr. Frydas Ilias is a molecular virologist who joined the EnvE Lab in January 2017. In November 2004 he started his studies at the Aristotle University of Thessaloniki, where he obtained a Diploma on Molecular Biology, Genetics and Biotechnology in November 2009. In summer 2009, he started working as an assistant researcher at the University Hospital of Thessaloniki (AHePa), studying various inflammatory pathways. In January 2011 he joined the Laboratory of Virology at the University of Ghent, in Belgium, where he started his PhD on PRRS virus. He worked at Celixir pharmaceutical company for six months as an assistant manager and an R&D researcher. In 2017, he got funding to perform his own research in developing adverse outcome pathways after exposure to ambient particles and evaluate the risk assessment in lung and liver cancer. Furthermore, he is involved as a postdoctoral researcher in different Horizon2020 projects.